Description
Expansion of the Montréal manufacturing capacity for COVID-19 vaccines, diverse injectable drugs and therapeutics with innovative state-of-the-art technology, facility expansion and retrofit and equip
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02021-09-16$23,800,000
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2021-09-16(start date) | $23,800,000 | — | Expansion of the Montréal manufacturing capacity for COVID-19 vaccines, diverse injectable drugs and therapeut… |
Related records · 5
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other recipients funded under "SIF Stream2- Growth" by Innovation, Science and Economic Development Canada | Innovation, Sciences et Développement économique Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 033-2025-2026-Q3-819843 | OmniaBio Inc. | FY2026 | $35,950,000 | FY2026 |
| 033-2024-2025-Q4-819872 | Teledyne Digital Imaging Inc | FY2025 | $8,000,000 | FY2025 |
| 033-2024-2025-Q4-820025 | Cedar LNG Partners LP | FY2025 | $200,000,000 | FY2025 |
| 033-2024-2025-Q4-819799 | Michelin North America (Canada) Inc. | FY2025 | $44,300,000 | FY2025 |
| 033-2024-2025-Q4-820219 | Cohere Inc. | FY2025 | $240,000,000 | FY2025 |
Cite as: Glassbox record view · Federal grants & contributions · 033-2022-2023-Q4-817399 · retrieved 2026-11-15.